(Q46331162)

21 December 2017

title

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis (English)

1 reference

21 December 2017

0 references

1 reference

E Bollschweiler

1

1 reference

21 December 2017

R Metzger

2

1 reference

21 December 2017

U Drebber

3

1 reference

21 December 2017

S Baldus

4

1 reference

21 December 2017

D Vallböhmer

5

1 reference

21 December 2017

M Kocher

6

1 reference

21 December 2017

A H Hölscher

7

1 reference

21 December 2017

publication date

3 October 2008

1 reference

21 December 2017

published in

Annals of Oncology

1 reference

21 December 2017

volume

20

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

231-238

1 reference

21 December 2017

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Definitive and neoadjuvant radiochemotherapy of squamous cell carcinoma of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Prognostic factors of resected adenocarcinoma of the esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Bone marrow—disseminated tumor cells in patients with carcinoma of the esophagus or cardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

Survival After Neoadjuvant Therapy Compared with Surgery Alone for Resectable Esophageal Cancer in a Population-based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN622

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN622

1 reference

21 December 2017

1 reference

21 December 2017